AsOf

Recorded or changed on this day 2026-11-08

601–650 of 46,473 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 5,504,000,000 United States dollar
AbbVie total equity: 5,504,000,000 United States dollar, claim clm_213580F78FFD · ended · superseded by clm_6F0CD2AA2AA9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 5,175,000,000 United States dollar
AbbVie cash and equivalents: 5,175,000,000 United States dollar, claim clm_213E56FCF1C0 · ended · superseded by clm_6EBD1BCE1675 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 2,761,000,000 United States dollar
AbbVie cash and equivalents: 2,761,000,000 United States dollar, claim clm_21E51F4C56F5 · ended · superseded by clm_D328E96523A5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · -738,000,000 United States dollar
AbbVie quarterly net income: -738,000,000 United States dollar, claim clm_22AD188AF61F · ended · superseded by clm_AB85F916C6BF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 4,897,000,000 United States dollar
AbbVie cash and equivalents: 4,897,000,000 United States dollar, claim clm_239801DFD565 · ended · superseded by clm_CAA6A1B515D0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,655,276,338 shares
AbbVie shares outstanding: 1,655,276,338 shares, claim clm_23EC71200821 · ended · superseded by clm_3ACFDECAD445 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,765,881,690 shares
AbbVie shares outstanding: 1,765,881,690 shares, claim clm_2867617AC03A · ended · superseded by clm_1D9411A9C895 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 89,115,000,000 United States dollar
AbbVie total assets: 89,115,000,000 United States dollar, claim clm_28B9101888C6 · ended · superseded by clm_9EF733A037E6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,628,542,359 shares
AbbVie shares outstanding: 1,628,542,359 shares, claim clm_28EEE079F857 · ended · superseded by clm_026545419A27 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 148,874,000,000 United States dollar
AbbVie total assets: 148,874,000,000 United States dollar, claim clm_29497973C1B0 · ended · superseded by clm_4B6461184F69 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,475,083,514 shares
AbbVie shares outstanding: 1,475,083,514 shares, claim clm_29853AC1B7D4 · ended · superseded by clm_F4CDCC85C327 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 15,002,000,000 United States dollar
AbbVie quarterly revenue: 15,002,000,000 United States dollar, claim clm_2A1D46B6132E · ended · superseded by clm_E6270C8DB4ED · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
AbbVie · net income · 4,226,000,000 United States dollar
AbbVie net income: 4,226,000,000 United States dollar, claim clm_2A3E6A20A337 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 6,432,000,000 United States dollar
AbbVie quarterly revenue: 6,432,000,000 United States dollar, claim clm_2A4B013AE0D7 · ended · superseded by clm_91E1E8F4CFBF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 59,441,000,000 United States dollar
AbbVie total assets: 59,441,000,000 United States dollar, claim clm_2ADF32E1BBE0 · ended · superseded by clm_28B9101888C6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 6,569,000,000 United States dollar
AbbVie cash and equivalents: 6,569,000,000 United States dollar, claim clm_2B61F63D78FE · ended · superseded by clm_A17F69D94691 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 3,010,000,000 United States dollar
AbbVie quarterly operating income: 3,010,000,000 United States dollar, claim clm_2B983894BFBB · ended · superseded by clm_CE5BF9768804 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 8,743,000,000 United States dollar
AbbVie cash and equivalents: 8,743,000,000 United States dollar, claim clm_2DEB42070657 · ended · superseded by clm_3AE3F00A4472 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · operating income · 5,817,000,000 United States dollar
AbbVie operating income: 5,817,000,000 United States dollar, claim clm_2E2748C2CF51 · ended · superseded by clm_A9B273E426B3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 13,927,000,000 United States dollar
AbbVie quarterly revenue: 13,927,000,000 United States dollar, claim clm_2E4438989255 · ended · superseded by clm_E449A119B758 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 5,640,000,000 United States dollar
AbbVie total equity: 5,640,000,000 United States dollar, claim clm_2ED4D5DFDB0F · ended · superseded by clm_C5F4EFA54CAC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 2,903,000,000 United States dollar
AbbVie quarterly operating income: 2,903,000,000 United States dollar, claim clm_2F093617D53B · ended · superseded by clm_0756AC49F7F1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 6,327,000,000 United States dollar
AbbVie cash and equivalents: 6,327,000,000 United States dollar, claim clm_307C886B12A3 · ended · superseded by clm_79527B6A026A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 15,270,000,000 United States dollar
AbbVie total equity: 15,270,000,000 United States dollar, claim clm_30B4D4FDA112 · ended · superseded by clm_B93B782FADFB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 2,957,000,000 United States dollar
AbbVie total equity: 2,957,000,000 United States dollar, claim clm_30E9608F5809 · ended · superseded by clm_4A958341B1C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · operating income · 17,924,000,000 United States dollar
AbbVie operating income: 17,924,000,000 United States dollar, claim clm_312A48E2B5D0 · ended · superseded by clm_810E9C4E1BC6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,617,358,607 shares
AbbVie shares outstanding: 1,617,358,607 shares, claim clm_3387E7EBA81F · ended · superseded by clm_28EEE079F857 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · revenue · 45,804,000,000 United States dollar
AbbVie revenue: 45,804,000,000 United States dollar, claim clm_34A920A5AE6F · ended · superseded by clm_D102FEEF7A89 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · net income · 11,542,000,000 United States dollar
AbbVie net income: 11,542,000,000 United States dollar, claim clm_37B2CAD3C6F1 · ended · superseded by clm_DEF5E95E0C29 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 8,449,000,000 United States dollar
AbbVie cash and equivalents: 8,449,000,000 United States dollar, claim clm_386994D20FBA · ended · superseded by clm_87EEBCE86395 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · operating income · 9,592,000,000 United States dollar
AbbVie operating income: 9,592,000,000 United States dollar, claim clm_386A79CBE5AB · ended · superseded by clm_C605181FAEA0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 41,142,000,000 United States dollar
AbbVie cash and equivalents: 41,142,000,000 United States dollar, claim clm_39876A48A684 · ended · superseded by clm_BBD4856469BA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · revenue · 19,960,000,000 United States dollar
AbbVie revenue: 19,960,000,000 United States dollar, claim clm_3A0D33F3133A · ended · superseded by clm_778004ECC385 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · -3,375,000,000 United States dollar
AbbVie total equity: -3,375,000,000 United States dollar, claim clm_3A571D375C13 · ended · superseded by clm_BEB3B81B5726 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,634,746,917 shares
AbbVie shares outstanding: 1,634,746,917 shares, claim clm_3ACFDECAD445 · ended · superseded by clm_66A3F5820C42 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 8,975,000,000 United States dollar
AbbVie cash and equivalents: 8,975,000,000 United States dollar, claim clm_3AE3F00A4472 · ended · superseded by clm_4FA738BFF268 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 4,563,000,000 United States dollar
AbbVie quarterly revenue: 4,563,000,000 United States dollar, claim clm_3B799E473A52 · ended · superseded by clm_DA4F15CF335B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · operating income · 3,620,000,000 United States dollar
AbbVie operating income: 3,620,000,000 United States dollar, claim clm_3C7DE622672F · ended · superseded by clm_2E2748C2CF51 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 6,009,000,000 United States dollar
AbbVie total equity: 6,009,000,000 United States dollar, claim clm_3CB07593AF7C · ended · superseded by clm_4023A402BB1E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · -350,000,000 United States dollar
AbbVie total equity: -350,000,000 United States dollar, claim clm_3D3AD133EF58 · ended · superseded by clm_30E9608F5809 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 14,653,000,000 United States dollar
AbbVie total equity: 14,653,000,000 United States dollar, claim clm_3DA39727C116 · ended · superseded by clm_D0C776D4C6FD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,478,821,109 shares
AbbVie shares outstanding: 1,478,821,109 shares, claim clm_3DCC4BB85B06 · ended · superseded by clm_8A7E2D59A0AB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 3,159,000,000 United States dollar
AbbVie quarterly operating income: 3,159,000,000 United States dollar, claim clm_3EFA0ADA51B8 · ended · superseded by clm_2B983894BFBB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · operating income · 7,537,000,000 United States dollar
AbbVie operating income: 7,537,000,000 United States dollar, claim clm_3F2A5C2764AA · ended · superseded by clm_D0B092E67442 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 6,687,000,000 United States dollar
AbbVie total equity: 6,687,000,000 United States dollar, claim clm_4023A402BB1E · ended · superseded by clm_512AA9C989B0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 148,858,000,000 United States dollar
AbbVie total assets: 148,858,000,000 United States dollar, claim clm_40C5FA2D2E2F · ended · superseded by clm_5711E0284444 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 5,524,000,000 United States dollar
AbbVie cash and equivalents: 5,524,000,000 United States dollar, claim clm_42142B046C44 · ended · superseded by clm_213E56FCF1C0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 29,045,000,000 United States dollar
AbbVie total assets: 29,045,000,000 United States dollar, claim clm_42B02BB64DBB · ended · superseded by clm_1BEC5D77F87E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · -8,226,000,000 United States dollar
AbbVie total equity: -8,226,000,000 United States dollar, claim clm_43A1D84452B5 · ended · superseded by clm_F246E0A322BD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 6,778,000,000 United States dollar
AbbVie total equity: 6,778,000,000 United States dollar, claim clm_44F4EB401556 · ended · superseded by clm_15A624C68E3C · 1 source (1 primary) · conf 0.95

What the statuses mean